Sex, M/F, n (%)
|
117 (66.9)/58(33.1)
|
104 (59.4)/71 (40.6)
|
0.184
|
Age, years [IQR]
|
52 [40.5-63]
|
52 [43.5-60]
|
0.654
|
Height, cm [IQR]
|
170 [165-176]
|
170 [164-176]
|
0.355
|
Weight, kg [IQR]
|
70 [62-80]
|
68 [55-78]
|
0.186
|
BMI, kg/m2 [IQR]
|
24.22 [22-26.2]
|
23.6 [20.4-26.1]
|
0.194
|
ASA, II/III/IV, n (%)
|
34 (19.4)/137(78.3)/4 (2.3)
|
26 (14.9)/148(84.6)/1 (0.6)
|
0.197
|
Neurovascular disease, n (%)
|
6 (3.4)
|
10 (5.7)
|
0.444
|
Respiratory disease, n (%)
|
18 (10.3)
|
26 (14.9)
|
0.195
|
• Obstructive, n (%)
|
8 (4.6)
|
11 (6.3)
|
0.638
|
• Other, n (%)
|
10 (5.7)
|
15 (8.6)
|
0.407
|
Cardiovascular disease, n (%)
|
137 (78.3)
|
147 (84)
|
0.219
|
• Hypertension, n (%)
|
124 (70.9)
|
130 (74.3)
|
0.549
|
• Other, n (%)
|
13 (7.9)
|
17 (9.7)
|
0.529
|
Abdominal disease, n (%)
|
63 (36)
|
79 (45.1)
|
0.102
|
Impaired glucose tolerance, n (%)
|
25 (14.3)
|
30 (17.1)
|
0.557
|
Dyslipidaemia, n (%)
|
30 (17.1)
|
32 (18.3)
|
0.889
|
Other disease, n (%)
|
16 (9.1)
|
13 (7.4)
|
0.699
|
Previous KTx, n (%)
|
18 (10.3)
|
16 (9.1)
|
0.857
|